← Latest news 
Biocon names niece Claire Mazumdar as successor after Kiran Mazumdar Shaw exit report
Entertainment
Published on 5 May 2026
A biotech heir from Bicara Therapeutics takes the helm
Biocon founder Kiran Mazumdar-Shaw has reportedly named her niece, Claire Mazumdar, as the company’s successor. Claire, founder and CEO of Bicara Therapeutics, brings advanced qualifications and prior industry experience. The announcement also comes amid broader structural and leadership changes across Biocon group firms as it pushes biosimilars and deeper artificial intelligence integration.
- Claire Mazumdar named as Biocon’s reported successor
- She leads Bicara Therapeutics and brings industry experience
- Biocon is also reshaping its structure and leadership
- Strategy emphasis includes biosimilars and AI integration
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times